Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention.
作者信息
Naik Bhiken I, Keeley Ellen C, Gress Daryl R, Zuo Zhiyi
机构信息
From the Department of Anesthesiology (B.I.N., Z.Z.), Division of Cardiovascular Medicine (E.C.K.), Department of Neurology (D.R.G.), University of Virginia, Charlottesville, Virginia.
出版信息
Anesthesiology. 2014 Sep;121(3):644-53. doi: 10.1097/ALN.0000000000000350.
Abstract
摘要
相似文献
1
Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention.病例情况：一名接受双重抗血小板治疗的患者在经皮冠状动脉介入治疗后发生颅内出血。
Anesthesiology. 2014 Sep;121(3):644-53. doi: 10.1097/ALN.0000000000000350.
2
Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.左主干冠状动脉支架置入术后双联抗血小板治疗的最佳持续时间
J Am Coll Cardiol. 2018 Oct 23;72(17):2086-2087. doi: 10.1016/j.jacc.2018.07.084.
3
Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.对接受双联抗血小板治疗的冠状动脉支架置入患者出血并发症的预测与管理。
BMJ. 2011 Jul 21;343:d4264. doi: 10.1136/bmj.d4264.
4
Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease.经皮冠状动脉介入治疗无保护左主干冠状动脉疾病后三联与双联抗血小板治疗的长期有效性和安全性
Coron Artery Dis. 2013 Nov;24(7):542-8. doi: 10.1097/MCA.0b013e328363abbd.
5
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.高出血风险患者经皮冠状动脉介入治疗后使用依维莫司洗脱支架行 1 个月双联抗血小板治疗。
Circ Cardiovasc Interv. 2020 Nov;13(11):e009565. doi: 10.1161/CIRCINTERVENTIONS.120.009565. Epub 2020 Nov 10.
6
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.在不受限制的经皮冠状动脉介入治疗人群中使用双联抗血小板治疗评分预测缺血和出血事件。
Circ Cardiovasc Interv. 2018 Oct;11(10):e006853. doi: 10.1161/CIRCINTERVENTIONS.118.006853.
7
8
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients.颅内出血与直接口服抗凝剂加单一抗血小板药物或三联抗栓治疗的支架血栓形成：房颤和经皮冠状动脉介入治疗/急性冠状动脉综合征患者随机试验的荟萃分析。
Europace. 2020 Apr 1;22(4):538-546. doi: 10.1093/europace/euz345.
9
Intracranial bleeding associated with clopidogrel.与氯吡格雷相关的颅内出血
Cardiovasc Drugs Ther. 2005 Mar;19(2):157-8. doi: 10.1007/s10557-005-0896-y.
10
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).全患者人群行经皮冠状动脉介入治疗后第一代或第二代药物洗脱支架或裸金属支架植入术后 2 年的结果：来自 PRODIGY 研究（支架内内膜增生分级后延长双联抗血小板治疗研究）的预先指定分析。
JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.
引用本文的文献
1
Emergency Neurosurgery in a Patient With Pacemaker: The Double Trouble.起搏器患者的急诊神经外科手术：双重麻烦
Cureus. 2024 Apr 14;16(4):e58256. doi: 10.7759/cureus.58256. eCollection 2024 Apr.
2
Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者中冠状动脉内应用尿激酶原的疗效及安全性：一项随机对照研究。
BMC Cardiovasc Disord. 2020 Jun 26;20(1):308. doi: 10.1186/s12872-020-01584-0.
3
Perioperative management of patient with intracoronary stent presenting for noncardiac surgery.因非心脏手术就诊的冠状动脉内支架置入患者的围手术期管理。
Ann Card Anaesth. 2016 Jan-Mar;19(1):122-31. doi: 10.4103/0971-9784.173028.
本文引用的文献
1
Hemorrhagic complications of ventriculostomy: incidence and predictors in patients with intracerebral hemorrhage.脑室引流相关出血并发症：脑出血患者的发生率及预测因素。
J Neurosurg. 2014 Apr;120(4):931-6. doi: 10.3171/2013.12.JNS131685. Epub 2014 Jan 10.
2
3
A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage.抗血小板治疗的创伤性颅内出血患者血小板功能的前瞻性评估。
J Trauma Acute Care Surg. 2013 Dec;75(6):990-4. doi: 10.1097/TA.0b013e3182a96591.
4
An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry.一种更新的出血模型，用于预测行经皮冠状动脉介入治疗患者术后出血的风险：使用国家心血管数据注册中心 CathPCI 注册库扩展的出血定义的报告。
JACC Cardiovasc Interv. 2013 Sep;6(9):897-904. doi: 10.1016/j.jcin.2013.04.016.
5
High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods.高剂量去铁胺治疗脑出血（HI-DEF）试验：原理、设计和方法。
Neurocrit Care. 2013 Oct;19(2):257-66. doi: 10.1007/s12028-013-9861-y.
6
Initial experiences with Multiplate® for rapid assessment of antiplatelet agent activity in neurosurgical emergencies.使用Multiplate®快速评估神经外科急诊中抗血小板药物活性的初步经验。
Clin Neurol Neurosurg. 2013 Oct;115(10):2003-8. doi: 10.1016/j.clineuro.2013.06.002. Epub 2013 Jul 2.
7
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.急性脑出血患者的血压快速降低。
N Engl J Med. 2013 Jun 20;368(25):2355-65. doi: 10.1056/NEJMoa1214609. Epub 2013 May 29.
8
Perioperative management of coagulation in nontraumatic intracerebral hemorrhage.非创伤性脑出血围手术期的凝血管理
Anesthesiology. 2013 Jul;119(1):218-27. doi: 10.1097/ALN.0b013e318297c18a.
9
Hematoma expansion following acute intracerebral hemorrhage.急性脑出血后的血肿扩大。
Cerebrovasc Dis. 2013;35(3):195-201. doi: 10.1159/000346599. Epub 2013 Feb 28.
10
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.普拉格雷与氯吡格雷用于急性冠脉综合征未血运重建患者。
N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512. Epub 2012 Aug 25.
Zotero 插件